Opinion: HIV 'morning after drug' can help end this pandemic

By now, we all know all too well there’s no one-size-fits-all solution to HIV/AIDS.

If we are really committed to finishing off something so complex as a 40-plus-year-old pandemic, we should expand our well-intentioned push for PrEP, or preexposure prophylaxis, to also highlight PEP — post-exposure prophylaxis, an intervention that’s largely ignored to the detriment of many who need it and want it.

Why is PEP glaringly nonexistent in HIV prevention programs — not only in Kenya, where we live and work, but also across the World Health Organization African region, with 25.6 million people living with HIV in 2022, and accounting for 50% of new HIV infections globally?  

This article is free to read - just register or sign in

Access news, newsletters, events and more.

Join us